Managing local language labeling and country specific requirements
Clinical trials are a global activity with clinical trial materials being shipped across many countries and many continents. For the sake of patient safety, the ability to control these materials’ labels at a global level is paramount. Labeling, booklets and single page leaflets must therefore be safely and accurately customized not only so that they are in the appropriate local languages, but also so they reflect country specific nuances; such as country specific designs and regulatory requirements.
Join us for ‘A Best Practice Guide to Clinical Trials Labeling’ on Wednesday, 28 January at 10:00 a.m. EST / 3:00 p.m. GMT. In this 60-minute, information-packed session, PRISYM ID explores the challenges involved in clinical trial local language labeling and country specific design.
Presented by
Vince Postill,
SVP Global Business Development, PRISYM ID
Vince Postill is responsible for business development via the channel at PRISYM ID, specializing in pharmaceutical and clinical trials. He has over 25 years’ experience within the Auto-ID market, delivering in both commercial and product development roles
Craig Jones,
VP Enterprise Sales Engineering, PRISYM ID
Craig Jones is the Vice President of Enterprise Sales Engineering for PRISYM ID with responsibility for understanding customer needs and industry challenges to drive solutions to improve efficiency, minimise risk, address regulatory requirements and provide new approaches to business systems and processes. Craig has 15 years of experience delivering validated label lifecycle management solutions to life science and healthcare industries including medical device, pharmaceutical and clinical trial organisations. His experience includes roles as an industry consultant, in IT management and as a senior manager for global technical support and professional services.
